Restenosis after Percutaneous Transluminal Coronary Angioplasty

Cytomegalovirus and restenosis after percutaneous transluminal coronary angioplasty.

Percutaneous Transluminal Coronary Angioplasty To the Editor: Manegold et al1 compared the incidence of prior cytomegalovirus (CMV) infection and the risk of restenosis after percutaneous transluminal coronary angioplasty (PTCA) in 92 consecutive patients. A total of 65% of these patients were positive for IgG CMV antibodies. At 6 months, angiographic restenosis was similar in CMV-positive and ...

Restenosis Rate After Multiple Percutaneous Transluminal Coronary

Background. Several studies suggest that repeated percutaneous transluminal coronary angioplasty procedures at the same site are associated with a progressively increasing risk of further restenosis and that short time intervals between successive procedures are predictive of future restenoses. Methods and Results. We assessed by quantitative coronary angiography the angiographic probability of...

Pathological findings after percutaneous transluminal coronary angioplasty.

Ten serial pathological cross sections at 1 mm intervals of both the left anterior descending artery at the site of a percutaneous transluminal coronary angioplasty and of the circumflex artery in the untreated stenotic area were studied at necropsy in a patient who died immediately after the procedure. The extent of calcification and atheroma were similar in both branches. Intimal or medial sp...

Percutaneous transluminal coronary angioplasty.

Percutaneous transluminal coronary angioplasty (PTCA) is a nonoperative mechanical dilatation of atherosclerotic coronary artery stenosis by a balloon-tipped dilating catheter system. This method can effectively reduce highly stenotic coronary lesions and provide early recovery of ischemic but viable myocardium. The technique of transluminal angioplasty was originally devised by Dotter and Judk...

Percutaneous transluminal coronary angioplasty.